Stretched Exponential Modeling Reveals Drug-Specific Kinetics in Human Engineered Skeletal Muscle

IF 3.7 3区 生物学 Q2 BIOPHYSICS
Mattias Luber,Bruno Schmelz,Christof Lenz,Timo Betz
{"title":"Stretched Exponential Modeling Reveals Drug-Specific Kinetics in Human Engineered Skeletal Muscle","authors":"Mattias Luber,Bruno Schmelz,Christof Lenz,Timo Betz","doi":"10.1016/j.bpj.2026.11.006","DOIUrl":null,"url":null,"abstract":"Understanding muscle tissue is key not only for advancing our knowledge of human biophysical function, but also for describing pathological states, improving treatment and providing insights for drug development. While using excised tissue is an excellent way to study muscular function, human tissue donation remains severely restricted, forcing reliance on non-human models.\nThe past decade has seen a rise in 3D in-vitro models of human skeletal muscle. However, many current experimental approaches struggle with the high variability of primary cells or the limited translational relevance of murine lines. Furthermore, state-of-the-art functional analysis typically focuses on peak force, which overlooks critical kinetic information. In this study, we present a systematic approach to generate functional engineered skeletal muscle tissues (ESMs), measure their contraction force dynamics, and model these dynamics to extract the effects of standard pharmacological modulators.\nWithin 14 days, ESMs based on the human immortalized LHCN-M2 cell line mature into aligned, multinucleated myofibers expressing key sarcomeric markers and exhibiting robust excitation-contraction coupling. To decode these dynamics, we introduce a novel mathematical model based on stretched exponential functions. This framework accurately captures heterogeneous contraction and relaxation phases across diverse phenotypes using only six interpretable parameters.\nWe validated the platform’s sensitivity using a library of pharmacological modulators. Our kinetic modeling revealed distinct parameter fingerprints for different drug classes, highlighting specific changes in contraction kinetics that peak force alone could not detect. Additionally, proteomic profiling confirmed the presence of necessary drug targets and established the maturation state of the tissue. Together, this study provides a scalable, high-fidelity human platform for high-content screening of contractile kinetics and muscle biophysics.","PeriodicalId":8922,"journal":{"name":"Biophysical journal","volume":"4 1","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biophysical journal","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1016/j.bpj.2026.11.006","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOPHYSICS","Score":null,"Total":0}
引用次数: 0

Abstract

Understanding muscle tissue is key not only for advancing our knowledge of human biophysical function, but also for describing pathological states, improving treatment and providing insights for drug development. While using excised tissue is an excellent way to study muscular function, human tissue donation remains severely restricted, forcing reliance on non-human models. The past decade has seen a rise in 3D in-vitro models of human skeletal muscle. However, many current experimental approaches struggle with the high variability of primary cells or the limited translational relevance of murine lines. Furthermore, state-of-the-art functional analysis typically focuses on peak force, which overlooks critical kinetic information. In this study, we present a systematic approach to generate functional engineered skeletal muscle tissues (ESMs), measure their contraction force dynamics, and model these dynamics to extract the effects of standard pharmacological modulators. Within 14 days, ESMs based on the human immortalized LHCN-M2 cell line mature into aligned, multinucleated myofibers expressing key sarcomeric markers and exhibiting robust excitation-contraction coupling. To decode these dynamics, we introduce a novel mathematical model based on stretched exponential functions. This framework accurately captures heterogeneous contraction and relaxation phases across diverse phenotypes using only six interpretable parameters. We validated the platform’s sensitivity using a library of pharmacological modulators. Our kinetic modeling revealed distinct parameter fingerprints for different drug classes, highlighting specific changes in contraction kinetics that peak force alone could not detect. Additionally, proteomic profiling confirmed the presence of necessary drug targets and established the maturation state of the tissue. Together, this study provides a scalable, high-fidelity human platform for high-content screening of contractile kinetics and muscle biophysics.
拉伸指数模型揭示了人类工程骨骼肌的药物特异性动力学
了解肌肉组织不仅是提高我们对人类生物物理功能知识的关键,也是描述病理状态、改善治疗和为药物开发提供见解的关键。虽然使用切除的组织是研究肌肉功能的一种极好的方法,但人体组织捐赠仍然受到严格限制,迫使人们依赖非人体模型。在过去的十年里,人类骨骼肌的3D体外模型出现了增长。然而,许多目前的实验方法与原代细胞的高可变性或小鼠系有限的翻译相关性作斗争。此外,最先进的功能分析通常侧重于峰值力,而忽略了关键的动力学信息。在这项研究中,我们提出了一种系统的方法来生成功能性工程骨骼肌组织(esm),测量它们的收缩力动力学,并建立这些动力学模型来提取标准药物调节剂的作用。在14天内,基于人类永生化LHCN-M2细胞系的esm成熟为排列的、多核的肌纤维,表达关键的肌肉标志物,并表现出强大的兴奋-收缩耦合。为了解码这些动态,我们引入了一种新的基于拉伸指数函数的数学模型。该框架仅使用6个可解释的参数准确地捕获了不同表型的异质收缩和松弛阶段。我们使用药理学调节剂库验证了该平台的敏感性。我们的动力学模型揭示了不同药物类别的不同参数指纹,突出了单峰值力无法检测到的收缩动力学的特定变化。此外,蛋白质组学分析证实了必要的药物靶点的存在,并确定了组织的成熟状态。总之,这项研究为高含量的收缩动力学和肌肉生物物理学筛选提供了一个可扩展的、高保真的人体平台。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Biophysical journal
Biophysical journal 生物-生物物理
CiteScore
6.10
自引率
5.90%
发文量
3090
审稿时长
2 months
期刊介绍: BJ publishes original articles, letters, and perspectives on important problems in modern biophysics. The papers should be written so as to be of interest to a broad community of biophysicists. BJ welcomes experimental studies that employ quantitative physical approaches for the study of biological systems, including or spanning scales from molecule to whole organism. Experimental studies of a purely descriptive or phenomenological nature, with no theoretical or mechanistic underpinning, are not appropriate for publication in BJ. Theoretical studies should offer new insights into the understanding ofexperimental results or suggest new experimentally testable hypotheses. Articles reporting significant methodological or technological advances, which have potential to open new areas of biophysical investigation, are also suitable for publication in BJ. Papers describing improvements in accuracy or speed of existing methods or extra detail within methods described previously are not suitable for BJ.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书